Janini - NIPT Non-Invasive Prenatal Test

Details of the Test:

Non-Invasive Prenatal Test (NIPT):
- Objective: Measures the amount of cell-free DNA (cfDNA) present in the mother’s blood to screen for certain genetic disorders, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
- How it Works: A sample of the mother's blood is collected, and the fetal DNA released from the placenta into the mother's bloodstream is analyzed. The test relies on advanced genetic screening technology to provide accurate results.

Suitable For:
- Pregnant Women: NIPT is suitable for all pregnant women, particularly:
- Women over the age of 35, as the risk of chromosomal abnormalities increases with age.
- Women with a family history of genetic disorders.
- Women who have received abnormal results from traditional screening tests, such as the Nuchal Translucency (NT) test.
- Women seeking a non-invasive method to assess fetal health.

Advantages
- High Accuracy: NIPT provides high accuracy in detecting genetic disorders compared to other tests.
- Safe and Non-Invasive: The test is performed by analyzing a sample of the mother’s blood, which means there is no risk to the fetus, unlike some other tests.
- Quick Turnaround Time: Provides fast results within a short period, helping parents make appropriate decisions swiftly.

Note:
This test can be performed at 10 weeks of pregnancy. It screens for fetal gender, as well as Down syndrome, Patau syndrome, and Edwards syndrome.

Conclusion
The "Janini - NIPT" testing package represents a valuable tool for assessing fetal health, allowing parents to obtain important information that contributes to making informed decisions regarding health care. This test is favored by many pregnant women due to its accuracy and safety.